期刊文献+

γ-干扰素对TRAIL诱导人甲状腺癌细胞凋亡影响的研究 被引量:2

Effect of IFN-γ on TRAIL-induced apoptosis of human thyroid cancer cells
原文传递
导出
摘要 目的:探讨γ-干扰素(IFN-γ)对TRAIL诱导人甲状腺癌细胞凋亡作用的影响。方法:流式细胞术、蛋白质印迹法、蛋白质羰基测定法和共聚焦显微镜分别用于检测细胞凋亡、GAPDH蛋白表达、氧化损伤程度和细胞核内GAPDH免疫染色表达。运用微小RNA干扰技术下调GAP-DH表达。结果:与耐药细胞系相比,TRAIL敏感的FRO和KTC2细胞核提取液中可见不同程度的GAPDH蛋白表达、细胞内羰基蛋白显著集聚。IFN-γ可增加耐药ARO细胞核中GAPDH水平。IFN-γ或TRAIL单药组细胞凋亡率均<5%,而IFN-γ/TRAIL联合组细胞凋亡率达28.5%。siGAPDH组与siRNA对照组间细胞凋亡率差异有统计学意义(t=4.909,P=0.08),使对照组细胞凋亡率下降11%。结论:IFN-γ加强TRAIL诱导人甲状腺癌细胞凋亡可能是通过上调细胞核内GAP-DH表达实现的。 OBJECTIVE:To determine the effect of IFN-γ on TRAIL-induced apoptosis of human thyroid cancer cells. METHODS: Flow cytometry (FCM) and Western blot analysis were respectively employed for apoptotic analysis and GAPDH protein expression. Protein carbonyl assay and confocal microscopy were respectively used for evaluation of oxidative damage and immunohistochemical expression of GAPDH in nuclei. GAPDH gene expression was downregulated by using small interfering RNA (siRNA) technique. RESULTS: GAPDH was observed in the nuclear fraction in TRAIL-sensitive FRO and KTC2 cells, but not ARO, KTC1, and KTC3 cells. Carbonyls were detected in FRO and KTC2 cells, but not in the other cell lines. IFN-γ increased the expression level of GAPDH in nuclear fraction of TRAIL-resistance ARO cells. The apoptosis rate of the IFN-γ or TRAIL single drug group was less than 5%, but that of the IFN-γ/TRAIL group was 28.5%. The difference of apoptosis rates between the siGAPDH group and siRNA control group(11%) was statistical significant(t=4.909,P=0.08). CONCLUSION: IFN-γ enhancing TRAIL-induced apoptosis of human thyroid cancer cells may be through the upregulation of nucleic expression of GAPDH.
出处 《中华肿瘤防治杂志》 CAS 2009年第6期406-409,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30740086) 沈阳市科技基金(1063316-1-00)
关键词 甲状腺肿瘤 干扰素Ⅱ型 细胞凋亡 thyroid neoplasms interferon typeⅡ apoptosis
  • 相关文献

参考文献11

  • 1Bossen C, Ingold K, Tardivel A, et al. Interactions of TNF and TNF receptor family members in the mouse and human[J]. J Biol Chem, 2006, 281(20) : 13964-13971.
  • 2Song J H, Bellail A, Tse M C, et al. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis- inducing ligand-induced apoptosis [ J]. J Neurosci, 2006, 26(12) : 3299-3308.
  • 3Yang Xuezhong, Merchant M S, Romero M E, et al. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) but reveals that a lack of membrane TR1/ TR2 also contributes to TRAIL resistance in NB[J]. Cancer Res, 2003, 63(5):1122-1129.
  • 4Sawa A, Khan A A, Hester L D, et al. Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death[J]. Proc Natl Acad Sci U S A, 1997,94(21) :11669-11674.
  • 5徐玉生,秦红霞,苗金红,杨迪生,许建中,张国富.TRAIL联合顺铂对横纹肌肉瘤细胞Fas表达和caspase3活性的影响[J].中华肿瘤防治杂志,2007,14(6):418-421. 被引量:7
  • 6杨阳,刘宝瑞,钱晓萍.TRAIL联合化疗或热疗抑制人肝癌细胞SMMC-7721体外增殖作用的研究[J].中华肿瘤防治杂志,2006,13(14):1064-1067. 被引量:5
  • 7Senatorov V V, Charles V, Reddy P H, et al. Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease [J]. Mol Cell Neurosci, 2003,22(3) :285-297.
  • 8Izeradjene K, Douglas L, Tillman D M, et al. Reactive oxygen species regulate caspase activation in tumor necrosis factorrelated apoptosis-inducing ligand-resistant human colon carcinoma cell lines[J]. Cancer Res, 2005,65(16) :7436-7445.
  • 9Okano H, Shirako K, Inoue H, et al. Cellular FLICE/caspase-8- inhibitory protein as a principal regulator of cell death and survival in human hepatocellular careinoma[J]. Lab Invest, 2003, 83(7) : 1033-1043.
  • 10Kandasamy K, Srinivasula S M, Alnemri E S, et al. Involvement of proapoptptic molecules Bax and Bak in tumornecrosis factor-related apoptosis-iinducing legend(TRAIL)-incluced mitochondrial disruption and apoptosis: differential reglation of cytochrome c and Smac/DIA- BLO release[J]. Cancer Res, 2003,63(7) : 1712-1721.

二级参考文献11

  • 1Wiley S R, Schooley K, Smolak P J, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity, 1995, 3(6): 673-682.
  • 2Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling,biology, and potential for cancer therapy[J]. Cytokine Growth Factor Rev, 2003, 14(3-4): 337-348.
  • 3Jo M, Kim T H, Seol D W, et al. Apoptosi.s induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-in-ducing ligand[J]. Nat Med, 2000, 6(5): 564-567.
  • 4Nagane M, Pan G, Weddle J J, et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo[J]. Cancer Res, 2000,60(4): 847-853.
  • 5Chinnaiyan A M, Prasad U, Shankar S, et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy[J]. Proc Natl Acad Sci USA, 2000,97(4): 1754-1759.
  • 6Yeh Y A, Herenyiova M, Weber G. Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells[J]. Life Sci, 1995, 57(13): 1285-1292.
  • 7Sprick M R, Weigand M A, Rieser E, et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2[J]. Immunity, 2000, 12(6): 599-609.
  • 8Kischkel F C, Lawrence D A, Chuntharapai A, et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5[J]. Immunity, 2000, 12(6): 611-620.
  • 9Gibson S B, Oyer R, Spalding AC, et al. Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL[J]. Mol Cell Biol, 2000, 20(1): 205-212.
  • 10Liu W, Bodle E, Chen J Y, et al. Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lincs[J]. Am J Respir Cell Mol Biol, 2001, 25(1): 111-118.

共引文献8

同被引文献35

  • 1姚悦萍,欧阳健,陈震章,侯亚义.肿瘤坏死因子相关的凋亡诱导配体受体在白血病细胞中的表达及其意义[J].临床内科杂志,2006,23(5):348-350. 被引量:5
  • 2郝建军,温实,卞永生.TRAIL、DcR1、DR4、Caspase-3与bcl-2在直肠癌及癌旁组织中的表达及其意义[J].中华实验外科杂志,2006,23(10):1269-1269. 被引量:4
  • 3Verbert L, Lee B, Kocks S, et al. Caspase-3-truneated typelinositol 1,4,5-trisphosphate receptor enhances intraeellular Ca^2+ leak and disturbs Ca^2+ signalling. Biol Cell ,2008,100( 1 ) :39-49.
  • 4Hartigan O,Connor DJ,Poon C,et al. Human CD4^+ regulatory T cell express lower levels of the IL-7 recepter alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods,2007,319(1-2) :41-52.
  • 5Paola S, Giorgio Z. Tumor necrosis factor-related apoptosis-indu- cing ligand and the regulation of hematopoiesis. Current Opinion in Hematology,2008,15 (7) :42-48.
  • 6Risitano AM, Maciejewski JP, Green S, et al. In-vivo dominant im- mune responses in aplastic anaemia:molecular tracking of putatively pathogvnetic T-cell clones by TCR beta-CDR3 sequencing. Lancet, ,364(9) :355-364.
  • 7Riley JK,Heeley JM,Wyman AH,et al. TRAIL and KILLER are expressed and induce apoptosis in the murine preimplantation em- bryo. Biol Reprod,2004,71 (3) :871-877.
  • 8Inagaki-Ohara K, Kondo T, Ito M,et al. SOCS, inflammation, and cancer[J]. JAKSTAT, 2013, 2(3) : e24053.
  • 9Royer MC, Zhang H, Fan CY, et al. Genetic alterations in pa- pillary thyroid carcinoma and hashimoto thyroiditis : an analysis of hOGG1 loss of heterozygosity[ J]. Arch Otolaryngol Head Neck Surg, 2010, 136(3) : 240-242.
  • 10Allavena P, Germano G, Marchesi F, et al. Chemokines in cancer related inflananation[ J]. Exp Cell Res, 2011,317(5) : 664-673.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部